First Horizon Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
4,295
+191
| +5% | +$4.65K | ﹤0.01% | 703 |
|
|
2025
Q1 | $85.2K | Hold |
4,104
| – | – | ﹤0.01% | 725 |
|
|
2024
Q4 | $96.6K | Hold |
4,104
| – | – | ﹤0.01% | 710 |
|
|
2024
Q3 | $105K | Sell |
4,104
-546
| -12% | -$14K | ﹤0.01% | 707 |
|
|
2024
Q2 | $109K | Buy |
4,650
+398
| +9% | +$9.35K | ﹤0.01% | 667 |
|
|
2024
Q1 | $122K | Buy |
4,252
+179
| +4% | +$5.15K | ﹤0.01% | 637 |
|
|
2023
Q4 | $134K | Buy |
4,073
+1,043
| +34% | +$34.2K | ﹤0.01% | 583 |
|
|
2023
Q3 | $84.4K | Buy |
3,030
+36
| +1% | +$1K | ﹤0.01% | 676 |
|
|
2023
Q2 | $102K | Buy |
2,994
+74
| +3% | +$2.52K | ﹤0.01% | 637 |
|
|
2023
Q1 | $87.8K | Buy |
2,920
+69
| +2% | +$2.08K | ﹤0.01% | 683 |
|
|
2022
Q4 | $80.5K | Buy |
2,851
+126
| +5% | +$3.56K | ﹤0.01% | 690 |
|
|
2022
Q3 | $89K | Buy |
2,725
+55
| +2% | +$1.8K | ﹤0.01% | 643 |
|
|
2022
Q2 | $84K | Buy |
+2,670
| New | +$84K | ﹤0.01% | 743 |
|
|
2022
Q1 | – | Sell |
-414
| Closed | -$25K | – | 1734 |
|
|
2021
Q4 | $25K | Sell |
414
-307
| -43% | -$18.5K | ﹤0.01% | 1188 |
|
|
2021
Q3 | $53K | Sell |
721
-139
| -16% | -$10.2K | ﹤0.01% | 870 |
|
|
2021
Q2 | $79K | Buy |
860
+121
| +16% | +$11.1K | ﹤0.01% | 621 |
|
|
2021
Q1 | $65K | Buy |
+739
| New | +$65K | ﹤0.01% | 637 |
|